Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Turcot syndrome 1 Rhabdoid Tumor 1 Pathologic Complete Response 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Carcinoma 1 Medulloblastoma 1 Lung Neoplasms 1 Esophagitis 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Anus Neoplasms 1

Interventions

pembrolizumab 7 Nivolumab 7 Specimen Handling 6 Mitomycin 6 Magnetic Resonance Spectroscopy 6 Capecitabine 6 Radiotherapy 5 Fluorouracil 4 Drug Therapy 4 Biopsy 4 Radiation 3 Paclitaxel 3 Ipilimumab 3 Fluorodeoxyglucose F18 3 Carboplatin 3 dehydroftorafur 2 atezolizumab 2 aldesleukin 2 Tomography, X-Ray Computed 2 Sigmoidoscopy 2 Radiotherapy, Intensity-Modulated 2 Proctoscopy 2 Mitozytrex 2 Colonoscopy 2 CTLA-4 Antigen 2 Adoptive Transfer 2 trastuzumab deruxtecan 1 spartalizumab 1 enzalutamide 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anus Neoplasms × Induction Chemotherapy × 1 year × Clear all

NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡